These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3904640

  • 1. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G, Ronchi E, Galassi A, Soli M, Botteghi B, Bercovich E.
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract] [Full Text] [Related]

  • 2. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S, Puzzo L, Di Naso C, Di Marco G, Ranno S, Minardi G.
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract] [Full Text] [Related]

  • 3. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G, Rauschmeier H, Rosmanith P, Hofstädter F.
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD, Makhlin NV.
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G, Altenaehr E.
    Cancer; 1982 Nov 15; 50(10):2052-6. PubMed ID: 6751517
    [Abstract] [Full Text] [Related]

  • 10. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
    Holmberg V, Wahren B, Esposti PL.
    Cytometry; 1984 Jul 15; 5(4):437-41. PubMed ID: 6380996
    [Abstract] [Full Text] [Related]

  • 11. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
    Moreno Sierra J, Ortega MD, Blanco Jimenez E, Maestro de las Casas ML, Delgado Marti JA, Hermida Gutierrez J, Salinas Casado J, Esteban Fuertes M, Resel Estévez L.
    Arch Esp Urol; 1994 Jul 15; 47(1):39-42. PubMed ID: 8192496
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H, Kobayashi I, Onishi Y, Igawa M, Ito H, Tahara E, Nihira H.
    J Urol; 1984 Feb 15; 131(2):252-7. PubMed ID: 6366250
    [Abstract] [Full Text] [Related]

  • 18. [Immunolabelling of urothelial bladder tumors. Value of 2 monoclonal antibodies and perspective in cytology].
    Pluot M, Bahroum K, Joundi A, Ducrot P, Diebold MD.
    Arch Anat Cytol Pathol; 1988 Feb 15; 36(3):69-74. PubMed ID: 2462408
    [No Abstract] [Full Text] [Related]

  • 19. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
    Nagata Y, Kinoshita H, Kawamura N, Sasadaira S.
    Hinyokika Kiyo; 1985 Nov 15; 31(11):1931-7. PubMed ID: 4091136
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.